Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00416312 · BASELINE

Baseline characteristics

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma · Source last updated 2018-08-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      9
    units
    Participants
groups
  1. description
    Tumor absorbed dose calculations determined using both conventional dosimetry and 3D-RD patient-specific dosimetry software.
    id
    BG000
    title
    Conventional & Patient-specific Dosimetry
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          1
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          6
        title
        >=65 years
      denoms
      1. counts
        1. group Id
          BG000
          value
          7
        units
        Participants
    param Type
    COUNT_OF_PARTICIPANTS
    population Description
    Tumors could not be detected on imaging for 2 of the 9 enrolled patients
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          6
        title
        Male
      denoms
      1. counts
        1. group Id
          BG000
          value
          7
        units
        Participants
    param Type
    COUNT_OF_PARTICIPANTS
    population Description
    Tumors could not be detected on imaging for 2 of the 9 enrolled patients
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Patients being treated for lymphoma using I-131-labeled antibody were imaged and tumor dosimetry was performed using conventional and patient-specific dosimetry. Tumors could not be detected on imaging for 2 of the 9 enrolled patients.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      9
    units
    Participants
groups
  1. description
    Tumor absorbed dose calculations determined using both conventional dosimetry and 3D-RD patient-specific dosimetry software.
    id
    BG000
    title
    Conventional & Patient-specific Dosimetry
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          1
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          6
        title
        >=65 years
      denoms
      1. counts
        1. group Id
          BG000
          value
          7
        units
        Participants
    param Type
    COUNT_OF_PARTICIPANTS
    population Description
    Tumors could not be detected on imaging for 2 of the 9 enrolled patients
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          6
        title
        Male
      denoms
      1. counts
        1. group Id
          BG000
          value
          7
        units
        Participants
    param Type
    COUNT_OF_PARTICIPANTS
    population Description
    Tumors could not be detected on imaging for 2 of the 9 enrolled patients
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Patients being treated for lymphoma using I-131-labeled antibody were imaged and tumor dosimetry was performed using conventional and patient-specific dosimetry. Tumors could not be detected on imaging for 2 of the 9 enrolled patients.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice